Cyclosporine in psoriasis: comparison of a 25-year real-world Italian experience to current European guidelines

G Ital Dermatol Venereol. 2016 Aug;151(4):432-5. Epub 2015 Mar 19.

Abstract

Cyclosporine (CsA) is an effective and safe therapeutic option in various dermatoses in both adults and children. Over the last 25 years, Italian dermatologists have gained relevant experience about the use of CsA in the treatment of psoriasis and atopic dermatitis, and an Italian Consensus Conference has recently provided recommendations in adult patients. A comparison between these real-world indications and current European guidelines is hereby provided.

MeSH terms

  • Adult
  • Child
  • Cyclosporine / therapeutic use*
  • Dermatitis, Atopic / drug therapy
  • Dermatitis, Atopic / pathology
  • Dermatologic Agents / therapeutic use*
  • Europe
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Italy
  • Practice Guidelines as Topic
  • Psoriasis / drug therapy*
  • Psoriasis / pathology

Substances

  • Dermatologic Agents
  • Immunosuppressive Agents
  • Cyclosporine